Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
VOLITIONRX LTD (VNRX)
Sector: Healthcare; Industry: Diagnostics & Research

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2022-08-02-05:00 Innes Guy Archibald Director Buy 312,500 $2.00 $625,000 No
2022-06-06-05:00 TERRELL JASON BRADLEY MD Chief Medical Officer Sell 14,949 $2.47 $36,924 No
2022-05-16-05:00 Innes Guy Archibald Director Buy 10,000 $2.37 $23,700 No
2022-04-11-05:00 TERRELL JASON BRADLEY MD Chief Medical Officer Sell 10,000 $2.75 $27,500 No
2021-11-16-05:00 Butera Salvatore Thomas CEO-Volition Veterinary Buy 10,000 $4.02 $40,200 No
2021-05-28 TERRELL JASON BRADLEY MD Chief Medical Officer Sell 10,000 $3.54 $35,400 No
2021-05-14 Nguyen Kim Director Buy 2,000 $3.20 $6,400 No
2021-05-17 Innes Guy Archibald Director Buy 150,000 $3.35 $502,500 No
2021-02-05 TERRELL JASON BRADLEY MD Chief Medical Officer Sell 10,000 $5.37 $53,700 No
2020-12-02 TERRELL JASON BRADLEY MD Chief Medical Officer Sell 10,000 $3.40 $34,000 No
2020-11-18 TERRELL JASON BRADLEY MD Chief Medical Officer Sell 5,000 $3.37 $16,849 No
2020-09-18 TERRELL JASON BRADLEY MD Chief Medical Officer Sell 19,500 $3.23 $62,985 Yes
2020-09-09 Faulkes Martin Charles Director Sell 65,000 $3.21 $208,650 No
2020-05-22 Reynolds Cameron John President and CEO Buy 4,000 $2.75 $11,000 No
2019-12-05 Reynolds Cameron John President and CEO Buy 1,100 $4.24 $4,664 No
2019-10-01 Eight Corp Ltd 10%-Owner Buy 50,000 $5.69 $284,570 No
2019-09-26 Eight Corp Ltd 10%-Owner Sell 46,238 $6.03 $278,792 No
2019-08-27 Faulkes Martin Charles Director Buy 10,000 $3.75 $37,500 No
2019-08-15 Faulkes Martin Charles Director Buy 50,000 $3.94 $197,000 No
2019-06-11 Faulkes Martin Charles Director Buy 79,269 $3.11 $246,134 No
2019-06-10 Faulkes Martin Charles Director Buy 70,731 $3.02 $213,608 No
2018-08-16 Innes Guy Archibald Director Buy 50,000 $2.00 $99,992 No
2018-08-16 Rootsaert Rodney Gerard Secretary Buy 5,000 $1.91 $9,550 No
2018-08-16 Reynolds Cameron John President and CEO Buy 6,500 $1.91 $12,415 No
2017-09-19 Vanston David Cecil CHIEF FINANCIAL OFFICER Buy 2,750 $2.84 $7,810 No
2017-08-16 Rootsaert Rodney Gerard Secretary Buy 3,630 $2.77 $10,055 No
2017-08-16 Reynolds Cameron John President and CEO Buy 3,630 $2.77 $10,055 No
2016-10-05 KRATOCHVIL DAVID MATTHEW Chief Financial Officer Buy 10,000 $5.00 $50,000 No
2016-05-20 Reynolds Cameron John President and CEO Sell 3,390 $3.54 $12,001 Yes
2015-05-15 Reynolds Cameron John President and CEO Buy 1,500 $3.33 $4,989 No

Insider Smart

CEDAR FAIR L.P. (FUN) - Another crash victim, Cedar Fair L.P. took a deep dive from $54 to $13, insiders were confidence and eagerly jumped in around $27. With insiders on your side, this would be an easy add and hold to get your cost under $20. Stock is about to breach $40 in the coming weeks.

Insider Smart

Celldex Therapeutics, Inc. (CLDX) - Multiple insiders including President, EVP, CEO, CSO and Directors bought shares on Jun.9th, first time since 2018, this was very convincing and we initiated a position. Stock soared from $3 to 9$ in 2 days, and the run is still going on.